
Caner Saygin MD
Hematology/Oncology
Assistant Professor of Medicine at the University of Chicago
Join to View Full Profile
5841 S Maryland AveChicago, IL 60637
Dr. Saygin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 2020 - 2023
- Ohio State University HospitalResidency, Internal Medicine, 2017 - 2020
- Cleveland ClinicPost-Doctoral Fellowship, 2015 - 2017
- Istanbul University, Cerrahpasa Faculty of MedicineClass of 2014
Certifications & Licensure
- IL State Medical License 2020 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- ASCO-Conquer Cancer Foundation Young Investigator Award ASCO-Conquer Cancer Foundation, 2022
- LLS Special Fellow Award Leukemia Lymphoma Society, 2022
- AACR/ASCO Methods in Clinical Cancer Research Workshop (Vail) AACR/ASCO, 2022
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsFactors associated with survival after allogeneic transplantation for myeloid neoplasms harboring TP53 mutations.Anmol Baranwal, Kimberly J Langer, Vedavyas Gannamani, Danielle Rud, Alia Cibich
Blood Advances. 2025-07-22 - Evolution of clonal hematopoiesis on and off lenalidomide maintenance for multiple myeloma.Jennifer H Cooperrider, Diren Arda Karaoglu, Tadeusz Kubicki, Can Rui Jiang, Ella Postich
Leukemia. 2025-07-16 - Outcomes for Patients With Myeloid Neoplasms Treated With Chemotherapy Plus Venetoclax After Prior Venetoclax Therapy.Rafael Madero-Marroquin, Joseph Cannova, Emily Dworkin, Austin Wesevich, Gregory W Roloff
Ejhaem. 2025-06-01
Press Mentions
- Comprehensive Care Improves Outcomes in Adult Lymphoblastic LeukemiaJanuary 18th, 2024
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: